View clinical trials related to Anesthesia.
Filter by:Patients undergoing stenting procedures, or cardiac or non-cardiac surgery could develop myocardial damage as testified by cardiac troponin release. Sevoflurane (volatile anesthetic), routinely used in cardiac and non-cardiac anesthesia, has cardioprotective properties that could be useful to reduce cardiac damage, as indicated by cardiac troponin release in different contexts: - stenting procedures (periprocedural administration) - non-cardiac surgery (during the whole procedure) - cardiac surgery (during the whole procedure)